orogen vet t(rf)
TRANSCRIPT
![Page 1: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/1.jpg)
By Leaps and By Leaps and BoundsBounds
What’s happening in medicine today can only be described a miraculous!
Information technologies and ‘instant communication’ capabilities
have enabled sharing and processing of vast amounts of information.
![Page 2: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/2.jpg)
Our bodiesOur bodies ‘know’ what to do ‘know’ what to do
Amazing as artificial intelligence and computers may be, our bodies are the most complex
and finely tuned creations of all.
Billions of bits of information are being processed and acted upon all at the same
time.
![Page 3: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/3.jpg)
One is Influenced One is Influenced by the Many . . . by the Many . . .
and in turn the Many are and in turn the Many are Influenced by the One!Influenced by the One!
We have just begun to scratch the surface of the enormity and complexity of it all.
![Page 4: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/4.jpg)
During our road trip During our road trip through life . . .through life . . .
maintenance and repair takes place every second, of every minute of every
day.
And when we stray from the normal path, experience fender-benders,
or just the day to day wear and tear catches up . . .
![Page 5: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/5.jpg)
. . . the time comes for a. . . the time comes for a tune up or repair. tune up or repair.
![Page 6: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/6.jpg)
We are learning. We are learning.
Our cells, tissues, and organs have a built in road map and GPS system.
When we get off course and need help, we hope to find the ‘RIGHT STUFF’ to get back on track!
![Page 7: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/7.jpg)
The TerrainThe TerrainThe pursuit of cures
for complex health problems has lead investigators
in pursuit of Regenerative Medicine.
Stem Cells Growth FactorsLaser Therapy
Nutrients
![Page 8: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/8.jpg)
Now that you get the conceptNow that you get the conceptits time to turn to the its time to turn to the
mechanicsmechanicsCompassionate Understanding Knowledge - to get the right diagnosisExperience - to perform at the leading edge Fair Price – for the latest technological
advances
![Page 9: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/9.jpg)
OroGen OroGen Biosciences Biosciences A forward thinking wound care and
regenerative medicine company
simplifying the complex . . . safely, economically and resourcefully.
![Page 10: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/10.jpg)
Formed in April 2008,
OROGEN BIOSCIENCES
specializing in Tissue Regenerative Biomatrix
![Page 11: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/11.jpg)
OROGEN OROGEN technologytechnology
Over 50,000 patients have benefited from this technology at the hands of the founders of OroGen without any evidence of cancer.
The unique proprietary processes discovered at OroGen intensify your own (autologous) tissue regenerative factors, preserving their function.
Advances have led to expanding the use of limited donor (allogeneic) resources through
preservation. (With even greater safety in use then provided
by blood banks! )
![Page 12: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/12.jpg)
Animal & Human Animal & Human CasesCases
The following cases are examples of the the use of
OroGen’s CanineTissue Regenerative Biomatrix
in supporting wound care and regenerative processes.
Equine and human cases provide further support of the technology.
![Page 13: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/13.jpg)
Canine Femoral Fracture 8/24/09 – Surgery Repair
10-22-09 8 weeks post op x-rays: non union with pin migration10-27-11 T(rf) injected at fracture site
![Page 14: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/14.jpg)
Post T(rf)) Injection 21 days 34 days
11-17-09 12-1-09
![Page 15: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/15.jpg)
Upper photos- 7 days after injury, T(rf) applied; lower left – 7 days ; lower left - 14 days
![Page 16: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/16.jpg)
HBC 1-12-11. Initial assessment HBC 1-12-11. Initial assessment pending a request for euthanasia. pending a request for euthanasia.
The client agreed to the terms of the clinical trial of The client agreed to the terms of the clinical trial of TT(rf))(rf))..
![Page 17: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/17.jpg)
1/19/11 One week after initial T 1/19/11 One week after initial T (rf) (rf) treatment and treatment and second application of T second application of T (rf) (rf) applied “SQ” to applied “SQ” to
‘devitalized’ areas and multiple ‘5/100 unit’ ‘devitalized’ areas and multiple ‘5/100 unit’ injections where no skin cover was present on distal injections where no skin cover was present on distal
leg.leg.
![Page 18: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/18.jpg)
3-29-11 3-29-11 Patient has full use Patient has full use of leg. Very active. of leg. Very active.
Any attempts to Any attempts to photograph medial photograph medial aspect of leg was aspect of leg was
unsuccessful due to unsuccessful due to motion blurring.motion blurring.
No complications No complications were noted from were noted from
JanuaryJanuary through March. through March.
Pelvic fractures Pelvic fractures stabilized with stabilized with
normal capacity to normal capacity to eliminate .eliminate .
![Page 19: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/19.jpg)
![Page 20: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/20.jpg)
Current case- unresponsiveto standard therapies. One application of Trf.
![Page 21: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/21.jpg)
Current Case
![Page 22: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/22.jpg)
![Page 23: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/23.jpg)
![Page 24: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/24.jpg)
Toe to be amputated following a year of unsuccessful attempts to stabilize.
![Page 25: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/25.jpg)
T(rf) has mostly been used with owners permission on a variety of patients including rescue cases that would have otherwise been euthanized including:
long bone fractures general soft tissue surgeries; severe bite wounds with extensive soft tissue trauma post Sx and no Sx stifle instability (especially geriatric cases); degenerative joint
disease comminuted mandibular fractures with concurrent oral disease; dentals performed and
fx sites injected, tape stabilization utilized chemo-extravascular injection necrosis elbow hygroma Chronic humeral-scapular joint tear with 30 degree range of motion -3 month duration,
poor response to NSAIDS and steroid injection : significant improvement followed by recurrence with unregulated exercise.
Severely Proliferative Cherry Eye in Bull Dogs with uncomplicated post op recovery and minimal to no swelling within 24 hr post Sx
KCS , one 5 day course of topical application - reduced the frequency of ophthalmic ointments for several months (client comments on phone follow up). Second case, stopped due to sting. Third case lost to follow up.
Personal observation: T(rf is a valuable addition/alternative to offer clients with limited options; as an adjunct therapy to common challenges; and for compromising surgeries. The full potential of this product will require more extensive and controlled studies. Until further studies are performed avoid using the product in the presence of neoplasia.
Dr Gary H Nelson, Viscaya Prado Veterinary Hospital, Cape Coral, FL
OROGEN OROGEN BIOSCIENCESBIOSCIENCES
![Page 26: Orogen vet t(rf)](https://reader036.vdocuments.pub/reader036/viewer/2022062310/58ec96ae1a28ab377f8b4581/html5/thumbnails/26.jpg)
5602 Marquesas Circle, Suite 214
Sarasota, FL 34233
Ph: 941-923-0009
www.orogen.net
OROGEN OROGEN BIOSCIENCESBIOSCIENCES